
Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Beat Estimates
Published on November 8, 2021
Amphastar (AMPH) delivered earnings and revenue surprises of 109.09% and 8.93%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
